Synthetic Biology Market
Synthetic Biology Market Size, Share & Trends Analysis Report by Deployment (Enabling Product, Core Product and Enabled Product), by Technology (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics and Others), and by Application (Medical Application, Industrial Application, Food &, Agriculture, and Environmental Application) Forecast Period, (2026-2035)
Industry Overview
Synthetic biology market valued at $16,502.6 million in 2025 and is projected to reach $74,176.2 million by 2035, growing at a CAGR of 16.3% during the forecast period (2026-2035). The global synthetic biology market is advancing as biotechnology firms, pharmaceutical companies, and research institutions intensify their focus on engineering-driven biological innovation and programmable biological systems. Growth is being reinforced by the expanding adoption of gene editing technologies such as CRISPR-Cas9, automated DNA synthesis, and biofoundry platforms that accelerate design-build-test cycles. Demand is further supported by the increasing need for sustainable bio-based production solutions across healthcare, agriculture, and industrial sectors. As regulatory bodies emphasize safe and standardized development of engineered organisms, synthetic biology platforms are becoming essential for improving efficiency, scalability, and reproducibility in biological research and manufacturing.
Market Dynamics
Rising Adoption of Engineering-Based Biology Across Industries
Organizations across pharmaceuticals, agriculture, and industrial biotechnology are increasingly integrating synthetic biology tools to design and optimize biological systems for targeted applications. The shift toward programmable biology is driving demand for platforms that support gene circuit design, metabolic pathway engineering, and microbial strain optimization. Companies are prioritizing technologies that enable faster prototyping and scalable production while reducing dependency on traditional chemical synthesis. As sustainability goals gain prominence, bio-based alternatives developed through synthetic biology are gaining wider acceptance. This transition toward engineered biological solutions is emerging as a major force shaping global market expansion.
Growing Integration of Automation, AI, and Bioinformatics in Synthetic Biology
Automation and artificial intelligence are being widely incorporated into synthetic biology workflows to streamline genetic design, predict biological behavior, and enhance experimental accuracy. Advances in machine learning, robotics, and high-throughput screening are enabling researchers to process large-scale biological datasets with improved speed and precision. Biofoundries and cloud-enabled platforms are supporting standardized and repeatable experimentation across multiple applications. Technology providers are focusing on scalable, modular systems that integrate seamlessly into existing laboratory infrastructure. As a result, the convergence of AI, automation, and synthetic biology is becoming a key driver of market growth.
Market Segmentation
- Based on the deployment, the market is segmented into enabling product, core product and enabled product.
- based on the technology, the market is segmented into gene synthesis & sequencing, genome engineering, bioinformatics and others.
- based on the application, the market is segmented into medical application, industrial application, food &, agriculture, and environmental application.
Enabling Product Segment to Dominate the Market with the Largest Share
In the global synthetic biology market, the enabling product segment is expected to account for the largest market share, driven by the increasing demand for foundational tools and platforms that support synthetic biology workflows. Enabling products, including reagents, enzymes, cloning kits, and synthesis tools, form the backbone of research and commercial applications across the industry. The growing adoption of advanced gene editing technologies, automation in laboratories, and high-throughput screening systems is significantly boosting demand for these products. Additionally, continuous innovation in DNA synthesis and sequencing technologies, along with expanding research activities in biotechnology and pharmaceutical sectors, is reinforcing the segment’s leading position in the market.
Medical Application Segment: A Key Contributor to Market Growth
The medical application segment plays a pivotal role in driving growth within the synthetic biology market, owing to its expanding use in drug discovery, gene therapy, vaccine development, and personalized medicine. Synthetic biology enables the design and engineering of biological systems for targeted therapeutic interventions, offering new possibilities for treating complex diseases. Rising investments in healthcare innovation, increasing prevalence of chronic and genetic disorders, and the growing focus on precision medicine are accelerating demand in this segment. Furthermore, advancements in genome engineering and bioinformatics are enhancing the efficiency, safety, and scalability of medical applications. These factors collectively position the medical application segment as a major contributor to overall market expansion.
Regional Outlook
The global synthetic biology market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
Strengthening Research and Innovation Ecosystem Across Europe
Europe is witnessing steady growth in the synthetic biology market as academic institutions, research organizations, and biotechnology companies expand their investments in advanced biological engineering capabilities. Collaborative initiatives supported by organizations such as European Commission are fostering cross-border research and innovation in areas such as bio-based chemicals, sustainable materials, and healthcare applications. Regional emphasis on biosafety, ethical standards, and environmental sustainability is encouraging the adoption of standardized synthetic biology platforms. Additionally, the expansion of bioeconomy programs is supporting commercialization efforts and strengthening the region’s innovation ecosystem.
North America Region Dominates the Market with Major Share
North America holds a dominant position in the synthetic biology market, supported by strong investments in research, advanced biotechnology infrastructure, and the presence of leading industry players. Organizations such as National Institutes of Health play a critical role in funding innovative research programs and accelerating the development of next-generation biological technologies. The region benefits from a mature ecosystem that integrates academia, startups, and large biopharmaceutical companies. Increasing partnerships between technology providers and research institutions are further driving adoption of synthetic biology tools. Regulatory support for innovation and commercialization is also contributing to the region’s strong market leadership.
Market Players Outlook
The major companies operating in the global synthetic biology market includes Agilent Technologies, Inc., Danaher Corporation, Illumina, Inc., Merck KGaA, Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Developments
- In July 2025, Ginkgo Bioworks expanded its biofoundry platform with advanced AI-driven organism design capabilities, enabling faster development of engineered microbes for applications in pharmaceuticals and specialty chemicals.
- In May 2025, Twist Bioscience introduced a next-generation DNA synthesis platform designed to improve throughput and accuracy in gene construction, supporting large-scale synthetic biology projects across research and industrial applications.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global synthetic biology Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Synthetic Biology Market Sales Analysis – Deployment | Technology | Application ($ Million)
- Synthetic Biology Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Synthetic Biology Market Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Synthetic Biology Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Synthetic Biology Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Synthetic Biology Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Synthetic Biology Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Synthetic Biology Market Revenue and Share by Manufacturers
- Synthetic Biology Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Agilent Technologies, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Danaher Corporation
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Illumina, Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck KGaA
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Thermo Fisher Scientific Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership and Collaboration
- Agilent Technologies, Inc.
- Key Company Analysis
- Global Synthetic Biology Market Sales Analysis by Deployment ($ Million)
- Enabling Product
- Core Product
- Enabled Product
- Global Synthetic Biology Market Sales Analysis by Technology ($ Million)
- Gene Synthesis & Sequencing
- Genome Engineering
- Bioinformatics
- Others
- Global Synthetic Biology Market Sales Analysis by Application ($ Million)
- Medical Application
- Industrial Application
- Food &, Agriculture
- Environmental Application
- Regional Analysis
- North American Synthetic Biology Market Sales Analysis – Deployment | Technology | Application | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Synthetic Biology Market Sales Analysis – Deployment | Technology | Application | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Synthetic Biology Market Sales Analysis – Deployment | Technology | Application | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Synthetic Biology Market Sales Analysis – Deployment | Technology | Application | Country ($ Million)
- Macroeconomic Factors for Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Agilent Technologies, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Amyris, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Arzeda Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Codexis, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Danaher Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Deep Genomics, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- DSM-Firmenich AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eurofins Scientific SE
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- GenScript Biotech Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ginkgo Bioworks Holdings, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Illumina, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Inscripta, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Integrated DNA Technologies, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck KGaA
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- New England Biolabs, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Novozymes A/S
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Oxford Nanopore Technologies plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Precigen, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Thermo Fisher Scientific Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Twist Bioscience Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Agilent Technologies, Inc.
1. Global Synthetic Biology Market Research and Analysis by Deployment, 2025–2035 ($ Million)
2. Global Enabling Product Synthetic Biology Market Research and Analysis by Region, 2025–2035 ($ Million)
3. Global Core Product Synthetic Biology Market Research and Analysis by Region, 2025–2035 ($ Million)
4. Global Enabled Product Synthetic Biology Market Research and Analysis by Region, 2025–2035 ($ Million)
5. Global Synthetic Biology Market Research and Analysis by Technology, 2025–2035 ($ Million)
6. Global Gene Synthesis & Sequencing Synthetic Biology Market Research and Analysis by Region, 2025–2035 ($ Million)
7. Global Genome Engineering Synthetic Biology Market Research and Analysis by Region, 2025–2035 ($ Million)
8. Global Bioinformatics Synthetic Biology Market Research and Analysis by Region, 2025–2035 ($ Million)
9. Global Others Synthetic Biology Market Research and Analysis by Region, 2025–2035 ($ Million)
10. Global Synthetic Biology Market Research and Analysis by Application, 2025–2035 ($ Million)
11. Global Synthetic Biology for Medical Application Market Research and Analysis by Region, 2025–2035 ($ Million)
12. Global Synthetic Biology for Industrial Application Market Research and Analysis by Region, 2025–2035 ($ Million)
13. Global Synthetic Biology for Food &, Agriculture Market Research and Analysis by Region, 2025–2035 ($ Million)
14. Global Synthetic Biology for Environmental Application Market Research and Analysis by Region, 2025–2035 ($ Million)
15. Global Synthetic Biology Market Research and Analysis by Region, 2025–2035 ($ Million)
16. North American Synthetic Biology Market Research and Analysis by Country, 2025–2035 ($ Million)
17. North American Synthetic Biology Market Research and Analysis by Deployment, 2025–2035 ($ Million)
18. North American Synthetic Biology Market Research and Analysis by Technology, 2025–2035 ($ Million)
19. North American Synthetic Biology Market Research and Analysis by Application, 2025–2035 ($ Million)
20. European Synthetic Biology Market Research and Analysis by Country, 2025–2035 ($ Million)
21. European Synthetic Biology Market Research and Analysis by Deployment, 2025–2035 ($ Million)
22. European Synthetic Biology Market Research and Analysis by Technology, 2025–2035 ($ Million)
23. European Synthetic Biology Market Research and Analysis by Application, 2025–2035 ($ Million)
24. Asia-Pacific Synthetic Biology Market Research and Analysis by Country, 2025–2035 ($ Million)
25. Asia-Pacific Synthetic Biology Market Research and Analysis by Deployment, 2025–2035 ($ Million)
26. Asia-Pacific Synthetic Biology Market Research and Analysis by Technology, 2025–2035 ($ Million)
27. Asia-Pacific Synthetic Biology Market Research and Analysis by Application, 2025–2035 ($ Million)
28. Rest of the World Synthetic Biology Market Research and Analysis by Region, 2025–2035 ($ Million)
29. Rest of the World Synthetic Biology Market Research and Analysis by Deployment, 2025–2035 ($ Million)
30. Rest of the World Synthetic Biology Market Research and Analysis by Technology, 2025–2035 ($ Million)
31. Rest of the World Synthetic Biology Market Research and Analysis by Application, 2025–2035 ($ Million)
1. Global Synthetic Biology Market Share by Deployment, 2025 Vs 2035 (%)
2. Global Enabling Product Synthetic Biology Market Share by Region, 2025 Vs 2035 (%)
3. Global Core Product Synthetic Biology Market Share by Region, 2025 Vs 2035 (%)
4. Global Enabled Product Synthetic Biology Market Share by Region, 2025 Vs 2035 (%)
5. Global Synthetic Biology Market Research and Analysis by Technology, 2025 Vs 2035 (%)
6. Global Gene Synthesis & Sequencing Synthetic Biology Market Share by Region, 2025 Vs 2035 (%)
7. Global Genome Engineering Synthetic Biology Market Share by Region, 2025 Vs 2035 (%)
8. Global Bioinformatics Synthetic Biology Market Share by Region, 2025 Vs 2035 (%)
9. Global Others Synthetic Biology Market Share by Region, 2025 Vs 2035 (%)
10. Global Synthetic Biology Market Research and Analysis by Application, 2025 Vs 2035 (%)
11. Global Synthetic Biology for Medical Application Market Share by Region, 2025 Vs 2035 (%)
12. Global Synthetic Biology for Industrial Application Market Share by Region, 2025 Vs 2035 (%)
13. Global Synthetic Biology for Food &, Agriculture Market Share by Region, 2025 Vs 2035 (%)
14. Global Synthetic Biology for Environmental Application Market Share by Region, 2025 Vs 2035 (%)
15. Global Synthetic Biology Market Research and Analysis by Region, 2025–2035 ($ Million)
16. US Synthetic Biology Market Size, 2025–2035 ($ Million)
17. Canada Synthetic Biology Market Size, 2025–2035 ($ Million)
18. UK Synthetic Biology Market Size, 2025–2035 ($ Million)
19. France Synthetic Biology Market Size, 2025–2035 ($ Million)
20. Germany Synthetic Biology Market Size, 2025–2035 ($ Million)
21. Italy Synthetic Biology Market Size, 2025–2035 ($ Million)
22. Spain Synthetic Biology Market Size, 2025–2035 ($ Million)
23. Russia Synthetic Biology Market Size, 2025–2035 ($ Million)
24. Rest of Europe Synthetic Biology Market Size, 2025–2035 ($ Million)
25. India Synthetic Biology Market Size, 2025–2035 ($ Million)
26. China Synthetic Biology Market Size, 2025–2035 ($ Million)
27. Japan Synthetic Biology Market Size, 2025–2035 ($ Million)
28. South Korea Synthetic Biology Market Size, 2025–2035 ($ Million)
29. Australia and New Zealand Synthetic Biology Market Size, 2025–2035 ($ Million)
30. ASEAN Economies Synthetic Biology Market Size, 2025–2035 ($ Million)
31. Rest of Asia-Pacific Synthetic Biology Market Size, 2025–2035 ($ Million)
32. Latin America Synthetic Biology Market Size, 2025–2035 ($ Million)
33. Middle East and Africa Synthetic Biology Market Size, 2025–2035 ($ Million)
- Printable version
- No restriction to number of users within the company
